Abstract
Objective
To analyse the expression of telomerase and apoptosis related protein, and explore the possible mechanism of breast cancer development.
Methods
Immunohistochemistry method (SP) was used to detect the expression of hTERT, p53 and bcl-2 in the tissues of 48 cases of human breast cancer and 42 cases of benign lesions in breast.
Results
The positive rates of expression of hTERT, p53 and bcl-2 in breast cancer were 87.50%, 56.25% and 54.17%, respectively. Compared with the groups of adjacent noncancerous and benign lesions, there was a significant difference among three types of tissues (P < 0.05). The positive rates of expression of p53 and bcl-2 in the group with positive expression of hTERT were 64.28% and 61.90%, respectively, and their difference was significant compared with the negative group (P < 0.05).
Conclusion
There is a correlation between the activation of telomerases and p53 gene mutation in the development of breast cancer, and they are perhaps relation to the down regulation of bcl-2.
Similar content being viewed by others
References
Li H, Liu JP. Signaling on telomerase: a master switch in cell aging and immortalization. Biogerontology, 2002, 3: 107–116.
Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science, 1997, 275: 973–977.
Blackburn EH. Telomeres and telomerase. Keio J Med, 2000, 49: 59–65.
Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res, 1995, 55: 3259–3262.
Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res, 1998, 58: 1558–1561.
Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science, 1995, 269: 1236–1241.
Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 1997, 90: 785–795.
Zhang ZW, Patchett SE, Farthing MJ. Role of Helicobacter pylori and p53 in regulation of epithelial cell cycle phase progression. Dig Dis Sci, 2002, 47: 987–985.
GAO G, Zhou CY, Lin ZY. The relationship between the gastric cancer and the Helicobacter pylori infection and the expression of c-myc, p53 gene. World J Gastroenterol (Chinese), 2000, 8: 941–943.
Harris AL. Mutation p53-the commonest genetic abnormality in human cancer. J Pathol, 1990, 162: 5–6.
Bonnefoy-Berard N, Aouacheria A, Verscheldee C, et al. Control of proliferation by Bcl-2 family members. Biochim Biophys Acta, 2004, 1644: 159–168.
Bosari S, Moneghini L, Graziani D, et al. bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinoma. Hum Pathol, 1995, 26: 534–540.
Wang XW, Guo XG, Bao L, et al. The expression of apoptosis regulation genes Bcl-2 and bad in benign and malignant breast tissues. Chin J Clin Oncol (Chinese), 2005, 32: 564–567.
Kusumoto M, Ogawa T, Mizumoto K, et al. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin Cancer Res, 1999, 5: 2140–2147.
Haldar S, Negrini M, Monne M, et al. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res, 1994, 54: 2095–2097.
Tsutsui S, Yasuda K, Suzuki K, et al. Bcl-2 protein expression is associated with p27 and p53 protein expression and MIB-1 counts in breast cancer. BMC Cancer, 2006, 6: 187.
Yang HY, Sun YT, Liu FS, et al. Expression of bcl-2 gene in relation to histologic type and grade. Chin J Oncol (Chinese), 2000, 22: 490–492.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by a grant from the Foundation of Health Department of Henan Province (No.20060038).
Rights and permissions
About this article
Cite this article
Li, M., Li, J., Su, J. et al. Expression of telomerase gene and apoptosis related genes in benign and malignant breast lesion. Chinese German J Clin Oncol 6, 361–364 (2007). https://doi.org/10.1007/s10330-007-0056-x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10330-007-0056-x